Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

HMS5552

Trial Locations (1)

Unknown

The 1st Betuhune Hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT02386982 - Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients | Biotech Hunter | Biotech Hunter